Home/Filings/4/0001127602-12-032757
4//SEC Filing

GLASER ROBERT 4

Accession 0001127602-12-032757

CIK 0000946840other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 4:08 PM ET

Size

13.1 KB

Accession

0001127602-12-032757

Insider Transaction Report

Form 4
Period: 2012-11-30
Transactions
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2012-11-3020,0000 total
    Exercise: $3.00From: 2006-02-09Exp: 2015-02-08Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2012-11-30$3.00/sh+20,000$60,00061,360 total
  • Exercise/Conversion

    Common Stock

    2012-11-30$20.15/sh+10,000$201,50051,360 total
  • Sale

    Common Stock

    2012-11-30$24.78/sh10,000$247,79541,360 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2012-11-3010,0000 total
    Exercise: $20.15From: 2007-02-20Exp: 2016-02-19Common Stock (10,000 underlying)
  • Sale

    Common Stock

    2012-11-30$24.78/sh20,000$495,59041,360 total
Footnotes (3)
  • [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $24.75 to $24.85, inclusive.
  • [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $24.75 to $24.85, inclusive.
  • [F3]The options vest in full one year from date of grant

Issuer

VIROPHARMA INC

CIK 0000946840

Entity typeother

Related Parties

1
  • filerCIK 0001187187

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:08 PM ET
Size
13.1 KB